BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21974702)

  • 1. Natural history of mineral and bone disorders after living-donor kidney transplantation: a one-year prospective observational study.
    Kawarazaki H; Shibagaki Y; Fukumoto S; Kido R; Ando K; Nakajima I; Fuchinoue S; Fujita T; Fukagawa M; Teraoka S
    Ther Apher Dial; 2011 Oct; 15(5):481-7. PubMed ID: 21974702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor kidney transplantation: a 1-year prospective observational study.
    Kawarazaki H; Shibagaki Y; Fukumoto S; Kido R; Nakajima I; Fuchinoue S; Fujita T; Fukagawa M; Teraoka S
    Nephrol Dial Transplant; 2011 Aug; 26(8):2691-5. PubMed ID: 21303965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Earlier decrease of FGF-23 and less hypophosphatemia in preemptive kidney transplant recipients.
    Barros X; Torregrosa JV; Martínez de Osaba MJ; Casals G; Paschoalin R; Durán CE; Campistol JM
    Transplantation; 2012 Oct; 94(8):830-6. PubMed ID: 23018879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation.
    Wolf M; Weir MR; Kopyt N; Mannon RB; Von Visger J; Deng H; Yue S; Vincenti F
    Transplantation; 2016 Jan; 100(1):184-93. PubMed ID: 26177089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical manifestations of hypercalcemia and hypophosphatemia after kidney transplantation.
    Kim YJ; Kim MG; Jeon HJ; Ro H; Park HC; Jeong JC; Oh KH; Ha J; Yang J; Ahn C
    Transplant Proc; 2012 Apr; 44(3):651-6. PubMed ID: 22483461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?
    Bhan I; Shah A; Holmes J; Isakova T; Gutierrez O; Burnett SM; Jüppner H; Wolf M
    Kidney Int; 2006 Oct; 70(8):1486-94. PubMed ID: 16941023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated fibroblast growth factor 23 levels as a cause of early post-renal transplantation hypophosphatemia.
    Han SY; Hwang EA; Park SB; Kim HC; Kim HT
    Transplant Proc; 2012 Apr; 44(3):657-60. PubMed ID: 22483462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study.
    Evenepoel P; Claes K; Kuypers D; Maes B; Bammens B; Vanrenterghem Y
    Nephrol Dial Transplant; 2004 May; 19(5):1281-7. PubMed ID: 14993493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors of post renal transplant hyperparathyroidism.
    Hamidian Jahromi A; Roozbeh J; Raiss-Jalali GA; Dabaghmanesh A; Jalaeian H; Bahador A; Nikeghbalian S; Salehipour M; Salahi H; Malek-Hosseini A
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):573-6. PubMed ID: 19587496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium and phosphate changes after renal transplantation.
    Messa P; Cafforio C; Alfieri C
    J Nephrol; 2010; 23 Suppl 16():S175-81. PubMed ID: 21170877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological analysis of persistent hypercalcemia and hyperparathyroidism after kidney transplantation in long-term dialysis patients.
    Nakamura M; Tanaka K; Marui Y; Tomikawa S
    Ther Apher Dial; 2013 Oct; 17(5):551-6. PubMed ID: 24107283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Evaluation of Mineral Metabolism After Kidney Transplantation.
    Alagoz S; Trabulus S
    Transplant Proc; 2019 Sep; 51(7):2330-2333. PubMed ID: 31402243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-transplant calcium-phosphate-parathormone homeostasis as a risk factor for early graft dysfunction.
    Ahmadi F; Ali-Madadi A; Lessan-Pezeshki M; Khatami M; Mahdavi-Mazdeh M; Razeghi E; Maziar S; Seifi S; Abbasi M
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):54-8. PubMed ID: 18087123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperparathyroidism and increased fractional excretion of phosphate predict allograft loss in long-term kidney transplant recipients.
    Prakobsuk S; Sirilak S; Vipattawat K; Taweesedt PT; Sumethkul V; Kantachuvesiri S; Disthabanchong S
    Clin Exp Nephrol; 2017 Oct; 21(5):926-931. PubMed ID: 27981393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of mineral metabolism markers on renal transplant outcomes.
    Marcén R; Jimenez S; Fernández A; Galeano C; Villafruela JJ; Burgos FJ; Quereda C
    Transplant Proc; 2012 Nov; 44(9):2567-9. PubMed ID: 23146456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineral metabolism in European children living with a renal transplant: a European society for paediatric nephrology/european renal association-European dialysis and transplant association registry study.
    Bonthuis M; Busutti M; van Stralen KJ; Jager KJ; Baiko S; Bakkaloğlu S; Battelino N; Gaydarova M; Gianoglio B; Parvex P; Gomes C; Heaf JG; Podracka L; Kuzmanovska D; Molchanova MS; Pankratenko TE; Papachristou F; Reusz G; Sanahuja MJ; Shroff R; Groothoff JW; Schaefer F; Verrina E
    Clin J Am Soc Nephrol; 2015 May; 10(5):767-75. PubMed ID: 25710805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in the pre-transplant bone-mineral metabolism do not affect the initial progress of the renal graft].
    Rodrigo Calabia E; Ruiz San Millán JC; Gago M; Ruiz Criado J; Piñera Haces C; Fernández Fresnedo G; Palomar R; Gómez Alamillo C; Martín de Francisco AL; Arias M
    Nefrologia; 2009; 29(2):143-9. PubMed ID: 19396320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor-23 and parathyroid hormone are associated with post-transplant bone mineral density loss.
    Kanaan N; Claes K; Devogelaer JP; Vanderschueren D; Depresseux G; Goffin E; Evenepoel P
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1887-92. PubMed ID: 20634326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum parathyroid hormone levels following renal transplantation: post-transplant hypercalcemia.
    Pierides AM; Thein-Than ; Cook DB
    Clin Nephrol; 1974; 2(4):136-42. PubMed ID: 4603151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.